HEMI PHARMA – TIRZEPATIDE (MOUNJARO) 5mg

Increased muscle mass: Tirzepatide has been shown to promote muscle growth and increase muscle mass in preclinical and early clinical studies. GLP-1 receptors are expressed in skeletal muscle, and activation of these receptors by tirzepatide may enhance muscle protein synthesis, leading to an increase in muscle size.

Improved insulin sensitivity: Tirzepatide, like other GLP-1 receptor agonists, improves insulin sensitivity by enhancing the body’s response to insulin. Insulin plays a crucial role in muscle protein synthesis and inhibiting muscle breakdown, thus creating an environment conducive to muscle growth.

Reduction in body fat: Tirzepatide has been shown to promote weight loss and reduce body fat in individuals with obesity or type 2 diabetes. By lowering overall body fat percentage, tirzepatide may help to enhance muscle definition and improve body composition.

Preservation of lean mass during weight loss: When individuals engage in weight loss efforts, there is often a risk of losing muscle mass along with fat. However, tirzepatide has demonstrated the potential to help preserve lean muscle mass during weight loss, which is essential for maintaining a healthy metabolism and functional strength.

Potential for exercise performance enhancement: Although further research is needed, some studies have suggested that GLP-1 receptor agonists, including tirzepatide, may improve exercise performance. By increasing muscle mass and enhancing energy utilization, tirzepatide may offer benefits for athletes and individuals looking to optimize their physical performance.